LncRNA Taurine Upregulated Gene 1 as a Potential Biomarker in the Clinicopathology and Prognosis of Multiple Malignant Tumors: A Meta-Analysis

Table 3

Correlation between lncRNA TUG1 and clinicopathological characteristics of tumors.

Clinicopathologial features	Number of cohorts	Number of patients	Pooled OR (95%CI)	value	Heterogeneity
					(%)	value
Gender (male vs. female)	31	1869	1.03 (0.84-1.25)	0.803	0	0.872
Age (<60 vs. ≥60)	15	1161	0.93 (0.73-1.18)	0.537	0	0.799
Tumor grade (low vs. high+moderate)	15	1332	1.99 (1.10-3.60)	0.023	80.7	<0.001
Tumor stage (III+IV vs. I+II)	20	1828	2.82 (1.84-4.33)	<0.001	72.2	<0.001
Lymph node metastasis (+ vs. -)	20	1835	2.96 (2.23-3.92)	<0.001	39.6	0.036
Distant metastasis (+ vs. -)	10	851	3.56 (1.97-6.41)	<0.001	57.1	0.013